Target intelligence / Profile preview

FOXP3 regulating long intergenic non-coding RNA (FLICR)

Target
FLICR
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA), Non-protein coding RNA
01

Overview

FOXP3 regulating long intergenic non-coding RNA (FLICR) is a long non-coding RNA located in close proximity to the Foxp3 gene and specifically expressed in mature regulatory T cells (Tregs)[1][2][4]. It acts as a negative regulator of Foxp3 expression, fine-tuning the amount of FoxP3 protein and thereby modulating Treg function and peripheral immune tolerance[1][4]. FLICR acts in cis, altering chromatin accessibility at conserved regions of the Foxp3 locus without affecting DNA methylation[1][4]. Its expression is particularly significant in conditions of low IL-2, with IL-2 signaling acting to repress FLICR[1][4]. Increased FLICR activity reduces Foxp3 and Treg suppressive activity, promoting susceptibility to autoimmune diseases such as type 1 diabetes, while diminished FLICR augments immune suppression and may impair anti-viral or anti-tumor responses[1][4]. FLICR is one of several lncRNAs that add a regulatory layer to Treg biology and immune homeostasis, but is not a protein, enzyme, or classical therapeutic target[1][2][4].

Other names
FlicrFoxp3 long intergenic noncoding RNAFOXP3 regulating lincRNA
02

Biological functions

Regulation of gene expression (specifically, Foxp3)Modulation of regulatory T cell (Treg) functionImmune tolerance modulationEpigenetic regulation (modulating chromatin accessibility)
03

Disease associations

AutoimmunityImmune tolerance (impact on type 1 diabetes, potentially other autoimmune diseases)(Indirectly) Infection and cancer (through altering Treg activity)
04

Safety considerations

Altered FLICR expression may affect susceptibility to autoimmune disease by destabilizing Treg functionPotential for dysregulated immune responses, both autoimmunity and impaired infection/cancer immunity

Beyond the preview

Go deeper on FOXP3 regulating long intergenic non-coding RNA (FLICR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FOXP3 regulating long intergenic non-coding RNA (FLICR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call